GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PsyBio Therapeutics Corp (TSXV:PSYB.H) » Definitions » Beta

PsyBio Therapeutics (TSXV:PSYB.H) Beta : 0.93 (As of Jun. 07, 2024)


View and export this data going back to 2021. Start your Free Trial

What is PsyBio Therapeutics Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-06-07), PsyBio Therapeutics's Beta is 0.93.


PsyBio Therapeutics Beta Historical Data

The historical data trend for PsyBio Therapeutics's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PsyBio Therapeutics Beta Chart

PsyBio Therapeutics Annual Data
Trend Dec21 Dec22
Beta
- -

PsyBio Therapeutics Quarterly Data
Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of PsyBio Therapeutics's Beta

For the Biotechnology subindustry, PsyBio Therapeutics's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PsyBio Therapeutics's Beta Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PsyBio Therapeutics's Beta distribution charts can be found below:

* The bar in red indicates where PsyBio Therapeutics's Beta falls into.



PsyBio Therapeutics Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


PsyBio Therapeutics  (TSXV:PSYB.H) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


PsyBio Therapeutics Beta Related Terms

Thank you for viewing the detailed overview of PsyBio Therapeutics's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


PsyBio Therapeutics (TSXV:PSYB.H) Business Description

Traded in Other Exchanges
Address
4400 Sample Road, Suite 138, Coconut Creek, FL, USA, 33073
PsyBio Therapeutics Corp is a biotechnology company. The company is engaged in the development of drugs intended for the treatment of mental illness and neurological disorders.

PsyBio Therapeutics (TSXV:PSYB.H) Headlines

No Headlines